- Nurofen and Dettel manufacturer Reckitt warns of potential £150m hit from Iran war oil costs Yorkshire Post —
- Dettol maker Reckitt warns of lower margins after quarterly sales miss Irish Times —
- Reckitt shares slump as Durex owner takes £150m Iran war hit City AM —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Standard —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Independent —
- Reckitt cautions over impact of Iran war on costs and consumer demand LBC —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Standard —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Independent —
- Reckitt cautions over impact of Iran war on costs and consumer demand Belfast Telegraph —
- Reckitt Sales Hit by Lackluster US Demand for Cold Medicines Bloomberg —
Reckitt warns of £150m war hit
Reckitt Benckiser shares slumped following a cautious trading update that highlighted the growing impact of the Middle East conflict on the real economy.
The company stated that a prolonged period of oil prices at $110 per barrel would significantly increase production costs for its plastic-heavy product lines.
Additionally, a weak cold and flu season in the US has further dampened revenue growth.
Management is now implementing cost-saving measures to offset the energy shock while warning that consumer demand may soften as inflation rises.